News
Epigral consolidated net profit declines 6.84% in the March 2026 quarter
02-May-2026 | 16:26
Sales rise 17.29% to Rs 736.16 crore
Net profit of Epigral declined 6.84% to Rs 80.95 crore in the quarter ended March 2026 as against Rs 86.89 crore during the previous quarter ended March 2025. Sales rose 17.29% to Rs 736.16 crore in the quarter ended March 2026 as against Rs 627.63 crore during the previous quarter ended March 2025.
For the full year,net profit declined 7.19% to Rs 331.97 crore in the year ended March 2026 as against Rs 357.69 crore during the previous year ended March 2025. Sales declined 0.90% to Rs 2527.18 crore in the year ended March 2026 as against Rs 2550.13 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 736.16 | 627.63 | 17 | 2527.18 | 2550.13 | -1 |
| OPM % | 22.77 | 27.62 | - | 22.40 | 27.87 | - |
| PBDT | 151.23 | 165.28 | -9 | 509.05 | 673.65 | -24 |
| PBT | 109.54 | 131.33 | -17 | 340.76 | 541.09 | -37 |
| NP | 80.95 | 86.89 | -7 | 331.97 | 357.69 | -7 |
Powered by Capital Market - Live News
